Highly Profitable Stocks to buy in 2021

The stock market faced numerous ups and downs during the year 2020. These were primarily due to the coronavirus pandemic and the 2020 US Presidential Elections for the election of the 46th President of the United States. The year was a year full of gains and profits for the stocks of some companies while various other companies had to face the wrath of the pandemic and their businesses got slowed down or shut down. Now, this year is a year of re-establishment for those companies and a year of gaining more for the companies who performed well last year. Here, let us discuss the stocks which will give great profits upon investment. In the case of these stocks, investors can expect good profits. These stocks will work out well for both the old shareholders and the new shareholders. Innovative Industrial Properties Inc. (NYSE: IIPR) 52 Week Range: $40.21 - $199.35 Average Volume: 475,650 Market Capital: $3.992B Forward Dividend and Yield: 96 (2.71%) Alphabet Inc (NASDAQ: GOOG) 52 Week Range: $1,013.54 - $1,847.20 Average Volume: 1,660,769 Market Capital: $1.177T Forward Dividend and Yield: N/A (N/A)   UnitedHealth Group Incorporated (NYSE: UNH) 52 Week Range: $187.72 - $367.95 Average Volume: 3,126,431 Market Capital: $327.153B Forward Dividend and Yield: 00 (1.43%)   Costco Wholesale Corporation (NASDAQ: COST) 52 Week Range: $271.28 - $393.15 Average Volume: 2,248,396 Market Capital: $166.436B Forward Dividend and Yield: 80 (0.74%)   Fiverr International Ltd. (NYSE: FVRR) 52 Week Range: $20.42 - $228.49 Average Volume: 1,311,331 Market Capital: $7.53B…

Amazon Inc. (NASDAQ: AMZN): A Stock that’s always a Better Buy

The e-commerce giant Amazon is a constantly rising company with a very tough potential. We can say this because, at the time of the coronavirus pandemic when so many companies incurred huge losses, this company continued to rise without fail. It is a stock that is perfectly suited for a long-term investment. It was amongst the best stocks even before the coronavirus pandemic began and during the pandemic, it rose fairly and faced hardly any declines. Amazon Prime: Rise in Subscriptions The price of the stock is however quite high but it is equally profit-giving as well. Amazon’s Amazon Prime subscriptions also increased this year because the cinema halls were closed due to the pandemic and the films were released via online platforms which gave a major boost to all the major online entertainment platforms. The increase in the number of subscriptions not only benefitted the earnings of Amazon but also the investors who invested in this company and received profits. Growth Rate and Statistics  If we consider the previous quarter, then the revenue growth rate of Amazon hastened by as much as 37%. Amazon also recently stepped into the pharmacy business which has added more fuel to its growth. If we talk about the growth in the case of the income per share, it has risen by 68%. In the case of the operating earnings, these have risen by 17%. Overall, as compared to the last year, i.e. 2019, Amazon has only grown despite the coronavirus pandemic which became…

Pfizer Stock: A Buy Now or Not?

The world is still struggling with the coronavirus pandemic and a vaccine is much required at this point. Pfizer’s vaccine has gained approval from the United States Food and Drug Administration (FDA) and some other countries are also approving the vaccine but still, the recent days have been the days of some ups and downs for Pfizer when it comes to the Stock Market sector. The stocks of this company fell low on some days. This has brought up the question, whether or not one should go for purchasing the stocks of Pfizer. Let us have a look at the latest statistical data of Pfizer Inc. and the company which is its partner in the Corona Virus vaccine, i.e., BioNTech SE – ADR: Pfizer Inc. (NYSE: PFE) Market Capital:  $228.561B Average Volume:  39,455,182 52 Week Range:  $26.45 - $43.08 Forward Dividend and Yield:  1.56 (3.79%) BioNTech SE – ADR (NASDAQ: BNTX) Market Capital:  $30.652B Average Volume:  3,634,690 52 Week Range:  $27.73 - $131.00 Forward Dividend and Yield:  N/A (N/A) Pfizer’s Effective Vaccine and other Reasons which make it a Buy Now Stock The vaccine that these two firms have jointly developed against the coronavirus is 95% effective against this infection and is formulated by the new messenger RNA, i.e. mRNA technique. In the previous time, hardly any vaccines have received approvals that were formulated using this same technology but this vaccine from Pfizer has made its way. The vaccine brought Pfizer into the limelight and since the past month when…